Inova Schar Cancer dosimetry team shines at AAMD International Planning Competition

Historic achievement showcases excellence in proton and photon therapy planning The medical dosimetry team at Inova Schar Cancer has achieved a historic milestone at the 2025 American Association of Medical Dosimetrists (AAMD) International Planning Competition, a globally recognized event showcasing cutting-edge treatment planning expertise. Competing against 194 submissions – 103 from the United States and…

Read More

Inova and the Virginia ACCESS Hub launch new study to evaluate multi-cancer detection tests

Inova, VCU, and Sentara enrolling participants in national study of blood tests designed to detect multiple cancer types Fairfax, VA – July 18, 2025  – Inova is now recruiting participants for the Vanguard Study, a national study of an innovative blood test that screens for several types of cancer. Researchers will evaluate whether these Multi-Cancer…

Read More

Inova Schar Cancer joins pioneering national effort to transform cancer care through ARPA-H’s ADAPT Program

Fairfax, VA – May 27, 2025 – Inova Schar Cancer is proud to participate in a groundbreaking national effort to transform how cancer is treated, through a major award from the Advanced Research Projects Agency for Health (ARPA-H). The initiative—ADvanced Analysis for Precision cancer Therapy (ADAPT)—aims to change the way cancer treatment decisions are made…

Read More